Search results
Research in context. Evidence before this study. Between January 2022 and August 2022 we searched PubMed and Cochrane Database of Systematic Reviews for umbrella reviews, systematic reviews and meta-analysis of randomised controlled trials (RCTs) concerning the effectiveness of cognitive behavioural therapy (CBT) vs any other control group for patients with schizophrenia spectrum disorders.
19 wrz 2024 · CIAS involves a wide variety of neurocognitive domains; attention, processing speed, working memory, learning and memory and executive functions are frequently and significantly impaired (1, 9, 10).
Background. Impairment in a wide range of cognitive abilities has been consistently reported in individuals with schizophrenia. Both neurocognitive and social cognitive deficits are thought to underlie severe functional disabilities associated with schizophrenia.
Cognitive impairment in schizophrenia is often severe, enduring, and contributes significantly to chronic disability. But clinicians have difficulty in assessing cognition due to a lack of brief instruments.
The Brief Assessment of Cognition in Schizophrenia (BACS) is a tool designed to measure cognitive functions in patients with schizophrenia. It consists of 6 subtests and takes less than 35 minutes to complete; based on their results, the overall score can be calculated. The Verbal Memory subtest involves repetition of a list of words 5
24 paź 2016 · Nuno Barbosa Rocha. Polytechnic Institute of Porto. Show all 7 authors. Citations (14) References (103) Abstract. OBJECTIVE: Cognitive Behavioral Therapy (CBT) has been recommended by several...
1 kwi 2006 · PDF/EPUB. Abstract. Cognitive-behavioral therapy (CBT) has a proven role as an adjunct to antipsychotic medication and remediative approaches such as social skills training in the management of residual symptoms of chronic schizophrenia.
